The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 05, 2023
Filed:
May. 28, 2021
Applicant:
Japan Tobacco Inc., Tokyo, JP;
Inventors:
Masahiro Yokota, Osaka, JP;
Noriyoshi Seki, Osaka, JP;
Eiichi Watanabe, Osaka, JP;
Shingo Fujioka, Osaka, JP;
Assignee:
Japan Tobacco Inc., Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/519 (2006.01); A61K 31/517 (2006.01); A61K 31/53 (2006.01); C07D 239/80 (2006.01); C07D 239/82 (2006.01); C07D 239/70 (2006.01); C07D 253/10 (2006.01); C07D 253/06 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 491/048 (2006.01); C07D 491/052 (2006.01); C07D 498/04 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 27/02 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); A61P 37/08 (2006.01);
U.S. Cl.
CPC ...
C07D 239/82 (2013.01); C07D 239/70 (2013.01); C07D 487/04 (2013.01); C07D 491/048 (2013.01); C07D 498/04 (2013.01);
Abstract
The present invention relates to saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds, or pharmaceutically acceptable salts having RORγ antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula [I] or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided: